FindTrial
Sign In

Comparative valuation of visibility and block characteristics of ultrasound TAP Block

Comparative evaluation of the visibility and block characteristics of an echogenic needle vs A non-echogenic needle for USG guided tap block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020423
Enrollment
70
Registered
2019-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ECHOGENIC NEEDLE: BUPIVACAINE 0.25% 20ml in bilateral transversus abdominal plane single shot injection Intervention2: NONECHOGENIC NEEDLE: BUPIVACAINE 0.25% 20ml in bilateral transvers

Sponsors

DEPARTMENT OF ANAESTHESIOLOGY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: â?? ASA grade I or II patients â?? Undergoing abdominal surgeries under GA/SAB â?? Patients aged 18 to 60 years, of either sex

Exclusion criteria

Exclusion criteria: 1. Patients with a history of cardiac, respiratory, renal or hepatic disease. 2. Local infection at the site of block. 3. Psychological disorders, 4. Allergy to study medications. 5. coagulation disorders.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be visibility of the block needle at the time of reaching the TAP plane according to the blinded observers 20 -30minutesTimepoint: The primary outcome of the study will be visibility of the block needle at the time of reaching the TAP plane according to the blinded observers—

Secondary

MeasureTime frame
5. number of skin punctures made; 6. number of catheter reinsertions required; 7. block success rate (as judged byVAS scores); 8. incidence of vascular puncture. Timepoint: 24 hrs—

Countries

India

Contacts

Public ContactDeepak Kumar Daunaria

KING GEORGE MEDICAL UNIVERSITY LUCKNOW

monica_kohli@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026